BIO-TECHNE Corp — Director's Dealing 2021

Aug 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2021-08-11

Reporting Person: Kummeth Charles R. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-11	Common Stock	M	921	$108.49	Acquired	165114	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-11	Stock Options (Right to Buy)	$108.49	M	921	Disposed	2022-08-07	Common Stock (921)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Indirect
Common Stock	100	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$106.59	2023-08-18	Common Stock (154169)	154169	Direct
Stock Options (Right to Buy)	$106.59	2023-08-18	Common Stock (102779)	102779	Direct
Stock Options (Right to Buy)	$125.05	2024-08-09	Common Stock (117342)	117342	Direct
Stock Options (Right to Buy)	$125.05	2024-08-09	Common Stock (78228)	78228	Direct
Stock Options (Right to Buy)	$177.32	2025-08-08	Common Stock (90334)	90334	Direct
Stock Options (Right to Buy)	$177.32	2025-08-08	Common Stock (60222)	60222	Direct
Restricted Stock Units	$		Common Stock (16937)	16937	Direct
Stock Options (Right to Buy)	$190.41	2026-08-07	Common Stock (85725)	85725	Direct
Stock Options (Right to Buy)	$190.41	2026-08-07	Common Stock (57150)	57150	Direct
Restricted Stock Units	$		Common Stock (12879)	12879	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (57442)	57442	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (38295)	38295	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (16650.0)	16650.0	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (16650)	16650	Direct
Restricted Stock Units	$		Common Stock (8016)	8016	Direct
Stock Options (Right to Buy)	$481.82	2028-08-06	Common Stock (31315)	31315	Direct
Stock Options (Right to Buy)	$481.82	2028-08-06	Common Stock (20876)	20876	Direct

Footnotes

F1: Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024.

F2: Fully exercisable.

F3: Options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022.

F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F5: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F6: Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.

F7: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F8: Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.

F9: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.

F10: Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.

F11: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F12: Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.